ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,068Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 617

$886K Total Retail Price of All Prescriptions

Rank: 10 out of 617

556 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,194 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 681 566 1 3
LEVOTHYROXINE SODIUM 374 266 2 1
WARFARIN SODIUM 369 296 3 7
FUROSEMIDE 354 310 4 4
CARVEDILOL 312 257 5 19
HYDROCODONE-ACETAMINOPHEN 280 196 S3 6 8
AMLODIPINE BESYLATE 256 208 7 6
GABAPENTIN 235 197 8 16
LISINOPRIL 223 164 9 5
ZOLPIDEM TARTRATE 219 166 10 23
SIMVASTATIN 212 152 11 2
POTASSIUM CHLORIDE 204 142 12 10
METFORMIN HCL 191 120 13 9
POLYETHYLENE GLYCOL 3350 188 143 14 32
BENZTROPINE MESYLATE 177 51 R 15 163
OLANZAPINE 171 73 16 139
LOSARTAN POTASSIUM 170 141 17 22
CITALOPRAM HBR 168 144 18 18
SPIRONOLACTONE 165 153 19 42
ATENOLOL 157 138 20 17
CRESTOR 149 82 21 28
SERTRALINE HCL 146 116 22 20
METFORMIN HCL ER 144 102 23 72
METOPROLOL SUCCINATE 138 111 24 12
METOPROLOL TARTRATE 136 98 25 11
HYDROCHLOROTHIAZIDE 130 122 26 13
LANTUS 124 103 27 39
DIVALPROEX SODIUM 120 19 28 111
ATORVASTATIN CALCIUM 117 78 29 14
PREDNISONE 117 101 29 31
QUETIAPINE FUMARATE 114 81 31 78
TAMSULOSIN HCL 111 102 32 26
CLOZAPINE 111 80 32 222
MELOXICAM 103 83 34 24
ESCITALOPRAM OXALATE 103 65 34 65
TRAMADOL HCL 101 82 36 15
DONEPEZIL HCL 100 94 37 30
NAMENDA 99 97 38 35
FAMOTIDINE 97 41 39 54
TRAZODONE HCL 93 41 40 51
MIRTAZAPINE 92 86 41 50
CHLORTHALIDONE 92 76 41 123
TOPIRAMATE 92 0 41 149
ADVAIR DISKUS 90 39 44 38
ALENDRONATE SODIUM 89 73 45 25
PROPRANOLOL HCL 81 50 46 109
OXYBUTYNIN CHLORIDE 81 72 46 88
ISOSORBIDE MONONITRATE ER 74 74 48 52
CYMBALTA 73 50 49 49
FENTANYL 68 65 S2 50 45
SINGULAIR 66 50 51 106
SEROQUEL XR 64 25 52 214
EXELON 63 63 53 156
DILTIAZEM ER 62 42 54 81
FLUTICASONE PROPIONATE 62 31 54 36
ABILIFY 61 17 56 131
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 50 57 29
PHENYTOIN SODIUM EXTENDED 58 36 58 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 46 59 91
NOVOLOG 53 36 60 137
ALLOPURINOL 53 50 60 27
WELCHOL 50 15 62 170
SUCRALFATE 50 41 62 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.